Monod - About the company
Monod is a seed company based in Seattle (United States), founded in 2021 by Alfredo Quijano Rubio and Daniel Silva Manzano. It operates as a Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules. Monod has raised $25M in funding from Matrix. The company has 113 active competitors, including 19 funded and 8 that have exited. Its top competitors include companies like ArgusEye, Hememics Biotechnologies and The Wave Talk.
Company Details
Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules. The company's platform is built from engineered proteins and de novo computational protein design to detect a wide range of target molecules.
Key Metrics
Founded Year
2021
Location
Seattle, United States
Stage
Seed
Total Funding
$25M in 2 rounds
Latest Funding Round
Ranked
1st among 113 active competitors
Employee Count
26 as on Sep 30, 2026
Legal entities associated with Monod
Monod is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Monod Bio Inc. CIN: 3-1154375 , United States, Active | Dec 31, 2020 | - | - | - |
Sign up to download Monod's company profile
Monod's funding and investors
Monod has raised a total funding of $25M over 2 rounds. Its first funding round was on Aug 15, 2022. Its latest funding round was a Grant (prize money) round on Jan 01, 2024 for $*****. 1 investor participated in its latest round. Monod has 8 institutional investors.
Here is the list of recent funding rounds of Monod:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 01, 2024 | 7317734 | Grant (prize money) | 4665584 | 7505016 | 1987787 | 6291833 |
Aug 15, 2022 | 5686013 | Seed | 8849765 | 3681226 |
View details of Monod's funding rounds and investors
Monod's founders and board of directors
Founder? Claim ProfileThe founders of Monod are Alfredo Quijano Rubio and Daniel Silva Manzano. Daniel Silva Manzano is the CEO of Monod.
Here are the details of Monod's key team members:
- Alfredo Quijano Rubio: Co-Founder of Monod. They serve on the board of 1 company.Contact Info: 1 email address
- Daniel Silva Manzano: Co-Founder & CEO of Monod. Contact Info: 1 email address
Monod's Board of Directors
Monod's board has 8 active members. Dave Johnson, Alfredo Quijano Rubio, Karan Takhar, Daniel Adriano Silva Manzano, David Shoultz, Berta Melina Cimler, Alfredo Quijano Rubio and David A Shoultz are independent board members.Here is the list of Monod's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 4y 10m | |
ivalylr | Independent board member | - | Current | 3y 4m |
plrptxj | Independent board member | - | Current | 7y 6m |
jumtnpa | Independent board member | - | Current | 1y 1m |
xounbka | Independent board member | - | Current | 4y 4m |
sqbrrgf | Independent board member | - | Current | 1y 2m |
xpbakff | Independent board member | - | Current | 4y 6m |
ukljvsm | Independent board member | - | Current | 4y 8m |
View details of Monod's Founder profiles and Board Members
Monod's employee count trend
Monod has 26 employees as of Sep 26. Here is Monod's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Monod's Competitors and alternates
Top competitors of Monod include ArgusEye, Hememics Biotechnologies and The Wave Talk. Here is the list of Top 10 competitors of Monod, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Monod 2021, Seattle (United States), Seed | Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules | $25M | 55/100 | |
2nd | Provider of biosensor solutions for real time detection of biological systems and processes | $3.02M | 52/100 | ||
3rd | Hememics Biotechnologies 2009, Gaithersburg (United States), Seed | Developer of techology platform for biopreservation | $4.6M | 51/100 | |
4th | The Wave Talk 2016, Seoul (South Korea), Seed | Developer of biosensors to detect and monitor micro-organisms | $2M | 45/100 | |
5th | Aligned Bio 2019, Lund (Sweden), Seed | Provider of nanowire-based sensors | $909K | 43/100 | |
6th | Cardea Bio 2019, San Diego (United States), Acquired | Developer of digital graphene biosensors using ML | $21.8M | 42/100 | |
7th | CyanoGuard 2016, Wadenswil (Switzerland), Seed | Developer of the next-generation cyanide monitoring device | $3.77M | 40/100 | |
8th | Assay Quant 2015, Marlborough (United States), Series A | Provider of SOX technology sensors for detection of protein kinase activity | $4.5M | 38/100 | |
9th | Crystal Diagnostics 1965, Broomfield (United States), Series A | Developer of technology solutions for pathogen testing of food produce | $2.9M | - | 37/100 |
10th | Annaida 2018, Lausanne (Switzerland), Seed | Developer of sensor using magnetic resonance | $1.06M | 37/100 |
Looking for more details on Monod's competitors? Click here to see the top ones
Monod's Investments and acquisitions
Monod has made no investments or acquisitions yet.
Reports related to Monod
Here is the latest report on Monod's sector:
News related to Monod
Media has covered Monod for a total of 4 events in the last 1 year, 3 of them have been about partnerships and 1 about company updates.
•
Monod Bio Licenses AI-Designed Protein Technologies to Sino Biological Subsidiary SignalChem BiotechNewMediaWire•Aug 26, 2026•Monod, Sino Biological
•
•
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod BioPR Newswire•Nov 18, 2025•Monod, Bio-Techne
•
•
•
•
•
Monod Bio Closes $25M Seed FinancingMedical Product Outsourcing•Sep 19, 2022•Monod, Z47, Global Health Investment, Cercano Management and 4 others
•
Biotech Startup Monod Bio Collects $25 Million Seed FinancingThe Wall Street Journal•Aug 15, 2022•Monod, http://monodbio.com, Matrix Partners India, Global Health Investment and 6 others
Are you a Founder ?
FAQs about Monod
Explore our recently published companies
- Kelly Car Wash - Warren based, Unfunded company
- Apex Glass Repair - Wake Forest based, Unfunded company
- Tow Time - Fountain Inn based, Unfunded company
- Blacktown Service Centre - Blacktown based, Unfunded company
- K2 Gold - Slovakia based, Unfunded company
- Minus Nine Auto Glass Care - Unfunded company
